BBUC Company Profile

The company declared that Sales have faded, during the second quarter of 2023 earnings season

For the fiscal period ending February 25 2023 Winnebago Industries Inc earnings per share plummeted by -43.49 % of $1.52 per share compare to $2.69 a year ago and profits fell by -12.14 % from $1.73 per share from the previous financial reporting period.

Sales crumbled by -25.588 % to $866.70 millions from $1.16 billions in the corresponding financial reporting period a year ago and sequentially Sales deteriorated by -8.979 % from $952.20 millions.

Sales Increased extensively at the company over the fourth quarter of 2022

In the fourth quarter of 2022 Chemung Financial Corp had Sales of $25.21 millions and earnings per share of $1.58. Sales were up by 11.5 % year on year and net profit per share grew by 14.41 %.

For the fiscal fourth quarter of 2022 company reached zero gain of $0.00 per share compare to $0.00 a year prior and from $0.00 per share from the prior reporting period.

Sales declined substantially by -12.314 % to $4.20 billions from $4.79 billions in the corresponding reporting period a year prior and sequentially Sales advanced from $0.00 millions.

Sales have tumbled at Telesis Bio Inc over the fourth quarter of 2022

Telesis Bio Inc reported disappointing Dec 31 2022 report, where Sales melted down by -41.976 % to $9.47 millions and the Laboratory Analytical Instruments company posted a shortfall per share to $-0.28, relative to $-0.58, in the corresponding span a previous year.

Pyxis Oncology Inc , deterioration in the corporate results throughout the fourth quarter of 2022 earnings season

The Major Pharmaceutical Preparations sector experts start to analyze the fourth quarter of 2022 earnings. Now those experts monitor operating loss of $-37.973 millions, from the PYXS, as it hasn't stated any revenue thus far, for the respective October to December 31 2022 quarter.